Chapter 1. CASTRATION-RESISTANT PROSTATE CANCER (CRPC)/HRPCA THERAPEUTICS MARKET– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. CASTRATION-RESISTANT PROSTATE CANCER (CRPC)/HRPCA THERAPEUTICS MARKET– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. CASTRATION-RESISTANT PROSTATE CANCER (CRPC)/HRPCA THERAPEUTICS MARKET– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. CASTRATION-RESISTANT PROSTATE CANCER (CRPC)/HRPCA THERAPEUTICS MARKET- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. CASTRATION-RESISTANT PROSTATE CANCER (CRPC)/HRPCA THERAPEUTICS MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. CASTRATION-RESISTANT PROSTATE CANCER (CRPC)/HRPCA THERAPEUTICS MARKET– By Type

6.1. Oral

6.2. Injectable

Chapter 7. CASTRATION-RESISTANT PROSTATE CANCER (CRPC)/HRPCA THERAPEUTICS MARKET– By Application

7.1. Hospitals & Clinics

7.2. Home Settings

7.3. Ambulatory Surgical Centers (ASCs)

Chapter 8. CASTRATION-RESISTANT PROSTATE CANCER (CRPC)/HRPCA THERAPEUTICS MARKET– By Region

8.1. North America

8.2. Europe

8.3. The Asia Pacific

8.4. Latin America

8.5. Middle-East and Africa

Chapter 9. CASTRATION-RESISTANT PROSTATE CANCER (CRPC)/HRPCA THERAPEUTICS MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

9.1. Company 1

9.2. Company 2

9.3. Company 3

9.4. Company 4

9.5. Company 5

9.6. Company 6

9.7. Company 7

9.8. Company 8

9.9. Company 9

9.10. Company 10